Abstract
Impaired diastolic function of the hypertrophied and stiffened left ventricle is a characteristic feature of hypertrophic cardiomyopathy [1–9]. The pathophysiologic basis and clinical significance of altered diastolic performance in this condition has been the subject of intense interest and investigation for the past two decades. Altered left ventricular filling dynamics and reduced left ventricular distensibility are associated with reduced left ventricular stroke volume, increased left ventricular filling pressures, and compressive effects on the coronary microcirculation. These factors contribute importantly to the clinical presentation of many patients, including symptoms of fatigue, dyspnea, and angina pectoris. Abnormal diastolic function has been demonstrated in the vast majority of patients with hypertrophic cardiomyopathy undergoing hemodynamic or noninvasive studies (Fig. 1.) [1–9]. This review will focus on the assessment of left ventricular diastolic function in hypertrophic cardiomyopathy, and the interplay between altered diastolic function and myocardial ischemia, using data derived from radionuclide techniques applied both in the noninvasive laboratory and in the catheterization laboratory.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Sanderson JE, Gibson DG, Brown DJ, Goodwin JF (1977) Left ventricular filling in hypertrophic cardiomyopathy: an angiographic study. Br Heart J 39: 661–670
Sanderson JE, Traill TA, St John Sutton MG, Brown DJ, Gibson DG, Goodwin JF (1978) Left ventricular relaxation and filling in hypertrophic cardiomyopathy: an echocardiographic study. Br Heart J 40: 596–601
St John Sutton MG, Tajik AJ, Gibson DG, Brown CJ, Seward JB, Giuliani ER (1978) Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis. Circulation 57: 512–520
Hanrath P, Mathey DG, Siegert R, Bleifeld W (1980) Left ventricular relaxation and filling in different forms of left ventricular hypertrophy: an echocardiographic study. Am J Cardiol 45: 15–23
Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC, Maron BJ, Leon MB, Epstein SE (1981) Effect of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 64: 787–796
Bonow RO, Frederick TM, Bacharach SL, Green MV, Goose PW, Maron BJ, Rosing DR (1983) Atrial systole and left ventricular filling in patients with hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol 51: 1386–1391
Alvares RF, Shaver JA, Gamble WH, Goodwin JF (1984) Isovolumic relaxation period in hypertrophic cardiomyopathy. J Am Coll Cardiol 3: 71–81
Betocchi S, Bonow RO, Bacharach SL, Rosing DR, Maron BJ, Green MV (1986) Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography. J Am Coll Cardiol 7: 74–81
Maron BJ, Spirito P, Green KJ, Wesley YE, Bonow RO, Arce J (1987) Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 10: 733–742
Gaasch WH, Levine HJ, Quinones MA, Alexander JK (1976) Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol 38: 645–653
Grossman W, Barry WH (1980) Diastolic pressure-volume relations in the diseased heart. Fed Proc 39: 148–155
Gaasch WH, Cole JS, Quinones MA, Alexander JK (1975) Dynamic determinants left ventricular pressure-volume relations in man. Circulation 51: 317–323
Bonow RO (1987) Left ventricular filling in ischemic and hypertrophic heart disease. In: Grossman W, Lorell BH (eds) Diastolic relaxation of the heart. Nijhoff, Boston, pp 231–243
Sordahl LA, McCollum WB, Wood WG, Schwartz A (1973) Mitochondria and sarco-plasmic reticulum function in cardiac hypertrophy and failure. Am J Physiol 224: 497–502
Ito Y, Suko J, Chidsey CA (1974) Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts. J Mol Cell Cardiol 6: 237–247
Lecarptenier Y, Martin L, Gastineau P, Hatt PY (1982) Load dependence of mammalian heart relaxation during cardiac hypertrophy and failure. Am J Physiol 242: H855–861
Gwathmey JK, Morgan JP (1985) Altered calcium handling in experimental pressure-overload hypertrophy in the ferrec. Circ Res 57: 836–843
Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP (1987) Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61: 70–76
Wagner JA, Sax FL, Weisman HF, Portersfield J, Mcintosh CL, Weisfeldt ML, Snyder SH, Epstein SE (1989) Calcium antagonist receptors are selectively increased in atrial tissue of patients with hypertrophic cardiomyopathy. N Engl J Med 320: 755–761
Pasternac A, Noble J, Streulens Y, Elie R, Henschke C, Bourassa MG (1982) Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 65: 778–798
Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE (1985) Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 71: 234–243
O’Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, Larson SM, Epstein SE (1987) Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 76: 1214–1223
Henry PD, Schuchleib R, David J, Weiss ES, Sobel BE (1977) Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol 233: H677–684
Nayler WG, Williams A (1978) Relaxation in heart muscle: Some morphologic and biochemical considerations. Eur J Cardiol 7 (suppl): 35–50
Nayler WG, Poole-Wilson PA, Williams A (1979) Hypoxia and calcium. J Mol Cell Cardiol 11: 683–706
Mann T, Goldberg S, Mudge GH, Grossman W (1979) Factors contributing to altered left ventricular diastolic properties during angina pectoris. Circulation 59: 14–20
Paulus WJ, Serizawa T, Grossman W (1982) Altered left ventricular diastolic properties during pacing-induced ischemia in dogs with coronary stenoses: potentiation by caffeine. Circ Res 50: 218–227
Carroll JD, Hess OM, Hirzel HO, Krayenbuehl HP (1983) Exercise-induced ischemia: the influence of altered relaxation on early diastolic pressures. Circulation 67: 521–528
Lorell BH, Wexler LF, Momomura S, Weinberg E, Apstein CS (1986) The influence of pressure hypertrophy on diastolic properties during hypoxia in isovolumically contracting rat hearts. Circ Res 58: 653–663
Wexler LF, Lorell BH, Monomura S, Weinberg EO, Ingwall JS, Apstein CS (1988) Enhanced sensitivity to hypoxia-induced diastolic dysfunction in pressure-overload left ventricular hypertrophy in the rat: role of high energy phosphate depletion. Circ Res 62: 766–775
Brutsaert DL, Housmans PR, Goethals MA (1980) Dual control of relaxation: its role in the ventricular function in the mammalian heart. Circ Res 47: 637–652
Brutsaert DL, Rademakers FE, Sys US (1983) Triple control of relaxation: implications in cardiac disease. Circulation 69: 190–196
Gaasch WH, Blaustein AS, Andrias CW, Donahue RP, Avitall B (1980) Myocardial relaxation. II. Hemodynamic determinants of rate of left ventricular pressure decline. Am J Physiol 239:Hl–6
Pouleur H, Rousseau MF, van Eyll C, Brasseur LA, Charlier A A (1983) Force-velocity- length relations in hypertrophic cardiomyopathy: evidence for normal or depressed myocardial contractility. Am J Cardiol 52: 813–817
Blaustein AS, Gaasch WH (1983) Myocardial relaxation. VI. Effects of beta-adrenergic tone and asynchrony on LV relaxation rate. Am J Physiol 244: H417–122
Brutsaert DL (1987) Nonuniformity: a physiologic modulator of contraction and relaxation of the normal heart. J Am Coll Cardiol 9: 341–348
Zile MR, Blaustein AS, Shimizu G, Gaasch WH (1987) Right ventricular pacing reduces the rate of left ventricular relaxation and filling. J Am Coll Cardiol 10: 702–709
Bonow RO (1990) Regional left ventricular nonuniformity: effects on left ventricular diastolic function in ischemic heart disease, in hypertrophic cardiomyopathy, and in the normal heart. Circulation (in press)
Bonow RO, Vitale DF, Maron BJ, Bacharach SL, Frederick TM, Green MV (1987) Regional left ventricular asynchrony and impaired global ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. J Am Coll Cardiol 9: 1108–1116
Hanrath P, Mathey DG, Kremer P, Sonntag F, Bleifeld W (1980) Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hyper-trophic cardiomyopathy. Am J Cardiol 45: 1258–1264
Lorell BH, Paulus WJ, Grossman W, Wynne J, Cohn PF (1982) Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 65: 499–507
Paulus WJ, Lorell BH, Craig WE, Wynne J, Murgo JP, Grossman W (1983) Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or impaired muscle inactivation? J Am Coll Cardiol 2: 879–886
Bonow RO, Ostrow HG, Rosing DR, Cannon RO, Lipson LW, Maron BJ, Kent KM, Bacharach SL, Green MV (1983) Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe. Circulation 68: 1062–1073
Hanrath P, Schlüter M, Sonntag F, Diemert J, Bleifeld W (1983) Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy. Am J Cardiol 52: 544–548
Suwa M, Hirota Y, Kawamura K (1984) Improvement in left ventricular diastolic function during intravenous and oral diltiazem therapy in patients with hypertrophic cardiomyopathy: an echocardiographic study. Am J Cardiol 54: 1047–1053
Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV (1985) Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 72: 853–864
Bonow RO (1985) Effect of calcium channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease. Am J Cardiol 55: 172B–178B
Hess OM, Murakami T, Krayenbuehl HP (1986) Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy? Circulation 74: 530–543
Iwase M, Sotobata I, Takagi S, Miyaguchi K, Jing HX, Yokota M (1987) Effects of diltiazem on left ventricular diastolic behavior in patients with hypertrophic cardiomyopathy: evaluation with exercise pulsed Doppler echocardiography. J Am Coll Cardiol 9: 1099–1105
Speiser KW, Krayenbuehl HP (1981) Reappraisal of the effect of acute beta blockade on left ventricular filling dynamics in hypertrophic obstructive cardiomyopathy. Eur Heart J 2: 21–29
Betocchi S, Cannon RO, Watson RM, Bonow RO, Ostrow HG, Epstein SE, Rosing DR (1985) Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy. Circulation 72: 1001–1007
Rosing DR, Kent KM, Borer JS, Seides SF, Maron BJ, Epstein SE (1979) Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation 60: 1201–1207
Walsh RA, O’Rourke RA (1985) Direct and indirect effects of calcium entry blocking agents on isovolumic relaxation in conscious dogs. J Clin Invest 75: 1426–1434
Udelson JE, Bonow RO, O’Gara PT, Maron BJ, Van Lingen A, Bacharach SL, Epstein SE (1989) Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 79: 371–382
Maron BJ, Epstein SE, Roberts WC (1979) Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 43: 1086–1102
St John Sutton MG, Lie JT, Anderson KR, O’Brien PC, Frye RL (1980) Histologic specificity of hypertrophic obstructive cardiomyopathy: myocardial fiber disarray and myocardial fibrosis. Br Heart J 44: 433–143
Rubin KA, Morrison J, Padrick MB, Binder AJ, Chiaramide S, Margouleff D, Padmanabhan VT, Gulotta SJ (1979) Idiopathic hypertrophic subaortic stenosis: evaluation of anginal symptoms with thallium-201 myocardial imaging. Am J Cardiol 44: 1040–1045
Pitcher D, Wainwright R, Maisey M, Curry P, Lowton E (1980) Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Br Heart J 44: 650–656
Hanrath P, Matthey D, Montz R, Thiel V, Vorbringer H, Kupper W, Schneider C, Bleifeld W (1981) Myocardial thallium-201 imaging in hypertrophic obstructive cardiomyopathy. Eur Heart J 2: 177–185
Nagata S, Park V-D, Nininikawa T, Yutani C, Kamiya T, Nishimura T, Kozuka T, Sakakibara H, Nimura Y (1985) Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy. Am Heart J 109: 1317–1322
O’Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, Larson SM, Epstein SE (1987) Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 76: 1214–1223
ten Cate FJ, Roelandt J (1979) Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J 97: 762–765
Ciro E, Maron BJ, Bonow RO, Cannon RO, Epstein SE (1984) Relation between marked changes in outflow tract gradient and disease progression in patients with hypertrophic cardiomyopathy. Am J Cardiol 53: 1103–1109
Spirito P, Maron BJ, Bonow RO, Epstein SE (1986) Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol 8: 537–544
Spirito P, Maron BJ, Bonow RO, Epstein SE (1987) Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 60: 123–129
Udelson JE, Maron BJ, O’Gara PT, Bonow RO (1989) Relation between left ventricular hypertrophy, filling, and perfusion in asymptomatic hypertrophic cardiomyopathy. J Am Coll Cardiol 13: 80A (abst)
Bonow RO, Mar on BJ, Leon MB, Cannon RO, Epstein SE (1988) Medical and surgical therapy of hypertrophic cardiomyopathy. In: Shaver J A (ed) Cardiomyopathies: clinical presentation, differential diagnosis, and management. Davies, Philadelphia, pp 221–239
Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL (1982) Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 307: 1362–1366
Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J, Kubler W (1984) Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 69: 1–7
James TH, Marshall TK (1975) De subitaneis mortibus. XII. Asymmetrical hypertrophy of the heart. Circulation 51: 1149–1166
Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8: 545–557
Morad M, Rolett EL (1972) Relaxing effects of catecholamines on mammalian heart. J Physiol (Lond) 224: 537–558
Udelson JE, Cannon RO, Bacharach SL, Rumble TF, Bonow RO (1989) Beta-adrenergic stimulation with isoproterenol enhances left ventricular diastolic performance in hypertrophic cardiomyopathy despite potentiation of myocardial ischemia: comparison to rapid atrial pacing. Circulation 79: 371–382
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bonow, R.O. (1990). Left Ventricular Diastolic Function and Myocardial Ischemia in Hypertrophic Cardiomyopathy: Assessment by Radionuclide Methods. In: Baroldi, G., Camerini, F., Goodwin, J.F. (eds) Advances in Cardiomyopathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83760-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-83760-9_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83762-3
Online ISBN: 978-3-642-83760-9
eBook Packages: Springer Book Archive